BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21593012)

  • 1. End-of-life care for lung cancer patients in the United States and Ontario.
    Warren JL; Barbera L; Bremner KE; Yabroff KR; Hoch JS; Barrett MJ; Luo J; Krahn MD
    J Natl Cancer Inst; 2011 Jun; 103(11):853-62. PubMed ID: 21593012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
    Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
    Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-of-life cancer care in Ontario and the United States: quality by accident or quality by design?
    Goodman D
    J Natl Cancer Inst; 2011 Jun; 103(11):840-1. PubMed ID: 21572061
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of Care and Costs for Older Patients With Colorectal Cancer at the End of Life: Descriptive Study of the United States and Canada.
    Bremner KE; Yabroff KR; Coughlan D; Liu N; Zeruto C; Warren JL; de Oliveira C; Mariotto AB; Lam C; Barrett MJ; Chan KK; Hoch JS; Krahn MD
    JCO Oncol Pract; 2020 Jan; 16(1):e1-e18. PubMed ID: 31647697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family Perspectives on Aggressive Cancer Care Near the End of Life.
    Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
    JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Long-term Mortality and Patterns of End-of-Life Care Among Medicare Sepsis Survivors Discharged to Home Health Care.
    Courtright KR; Jordan L; Murtaugh CM; Barrón Y; Deb P; Moore S; Bowles KH; Mikkelsen ME
    JAMA Netw Open; 2020 Feb; 3(2):e200038. PubMed ID: 32101307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.
    Teno JM; Gozalo PL; Bynum JP; Leland NE; Miller SC; Morden NE; Scupp T; Goodman DC; Mor V
    JAMA; 2013 Feb; 309(5):470-7. PubMed ID: 23385273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressiveness of intensive care use among patients with lung cancer in the Surveillance, Epidemiology, and End Results-Medicare registry.
    Cooke CR; Feemster LC; Wiener RS; O'Neil ME; Slatore CG
    Chest; 2014 Oct; 146(4):916-923. PubMed ID: 25117058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
    Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
    J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.
    McDermott CL; Bansal A; Ramsey SD; Lyman GH; Sullivan SD
    J Pain Symptom Manage; 2018 Nov; 56(5):699-708.e1. PubMed ID: 30121375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Hospice Services in the Care of Patients with Advanced Stage Nonsmall Cell Lung Cancer.
    Duggan KT; Hildebrand Duffus S; D'Agostino RB; Petty WJ; Streer NP; Stephenson RC
    J Palliat Med; 2017 Jan; 20(1):29-34. PubMed ID: 27559623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cost of Hospice Services in Terminally Ill Patients With Head and Neck Cancer.
    Enomoto LM; Schaefer EW; Goldenberg D; Mackley H; Koch WM; Hollenbeak CS
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1066-74. PubMed ID: 26447873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada.
    Ho TH; Barbera L; Saskin R; Lu H; Neville BA; Earle CC
    J Clin Oncol; 2011 Apr; 29(12):1587-91. PubMed ID: 21402603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the aggressiveness of cancer care near the end of life.
    Earle CC; Neville BA; Landrum MB; Ayanian JZ; Block SD; Weeks JC
    J Clin Oncol; 2004 Jan; 22(2):315-21. PubMed ID: 14722041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource use in the last three months of life by lung cancer patients in southern Ontario.
    Wang Y; Van Dam A; Slaven M; Ellis KJ; Goffin JR; Juergens RA; Ellis PM
    Curr Oncol; 2019 Aug; 26(4):247-252. PubMed ID: 31548804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between aggressive care and bereaved families' evaluation of end-of-life care for veterans with non-small cell lung cancer who died in Veterans Affairs facilities.
    Ersek M; Miller SC; Wagner TH; Thorpe JM; Smith D; Levy CR; Gidwani R; Faricy-Anderson K; Lorenz KA; Kinosian B; Mor V
    Cancer; 2017 Aug; 123(16):3186-3194. PubMed ID: 28419414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
    McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
    JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Hospice on Spending and Utilization Among Patients With Lung Cancer in Medicare.
    Kalidindi Y; Segel J; Jung J
    Am J Hosp Palliat Care; 2020 Apr; 37(4):286-293. PubMed ID: 31564110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population.
    Rasco DW; Yan J; Xie Y; Dowell JE; Gerber DE
    J Thorac Oncol; 2010 Oct; 5(10):1529-35. PubMed ID: 20631635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.